Seer, Inc.
SEER · XNASCIK 1726445fmd_01HEC6WWFRMSZE9EY3Q7RGQ294Manufacturing · Laboratory Analytical InstrumentsTemplate: Standard
Coverage: Jan 01, 2020 to Sep 30, 2026, 27 periods
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Total revenues | 1 | 7 | 15 | 17 | 14 | 17 |
| Rental revenue | – | – | – | 0 | – | – |
| Cost of revenue | 0 | 3 | 8 | 8 | 7 | 8 |
| Gross profit | 1 | 3 | 7 | 9 | 7 | 8 |
| Research and development | 19 | 29 | 46 | 53 | 51 | 44 |
| Selling, general and administrative | 15 | 46 | 59 | 59 | 57 | 43 |
| Total operating expenses | 34 | 75 | 104 | 112 | 107 | 86 |
| Compensation and benefits | – | – | – | 41 | 37 | 35 |
| Operating income | (34) | (71) | (97) | (103) | (100) | (78) |
| Interest expense | 0 | 0 | 0 | – | – | – |
| Interest and investment income | 1 | 0 | 5 | 18 | 17 | 12 |
| Other non-operating income (expense) | 1 | 0 | 4 | 17 | 14 | 5 |
| Income before taxes | – | – | – | (86) | (87) | (73) |
| Income tax expense | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income from continuing operations | – | – | – | (86) | (87) | (74) |
| Net income | (33) | (71) | (93) | (86) | (87) | (74) |
| Net income to common shareholders | (33) | (71) | – | – | – | – |